...
首页> 外文期刊>Journal of clinical biochemistry and nutrition. >Effect of egualen sodium hydrate on small-intestinal mucosal damage induced by low-dose aspirin: a prospective randomized clinical trial
【24h】

Effect of egualen sodium hydrate on small-intestinal mucosal damage induced by low-dose aspirin: a prospective randomized clinical trial

机译:水芹黄连酸钠对小剂量阿司匹林引起的小肠粘膜损伤的影响:一项前瞻性随机临床试验

获取原文
           

摘要

Low-dose aspirin, which is widely used to reduce the risk of cardio- and cerebrovascular thrombosis, often induces gastroenteropathy by increasing the permeability of the mucosa. However, therapeutic strategies for patients with low-dose aspirin-induced small intestinal injury have not been determined. We evaluated the preventative effect of egualen sodium hydrate, a gastro-protective agent that suppresses indomethacin-induced small-intestinal damage in rats, against small-intestinal mucosal damage induced by low-dose aspirin in healthy adult male volunteers. Participants were randomly allocated to receive aspirin 100?mg/kg daily (control group, n =?10) or aspirin 100?mg/kg plus egualen sodium 30?mg daily (egualen sodium group, n =?10). Small intestinal mucosal injury was evaluated by capsule endoscopy two weeks after initiation of drug administration. Fecal analyses (occult blood test, immunochemical test, transferrin measurement and calprotectin measurement) were carried out before and after treatment. Egualen sodium significantly suppressed the total number of small intestinal injuries detected by capsule endoscopy and the positive ratio for the fecal occult blood test. Daily use of 30?mg of egualen sodium showed a preventative effect on low-dose aspirin-induced small intestinal injury. Since acid suppression therapy was reported to exacerbate NSAIDs-induced enteropathy via dysbiosis, egualen sodium may be useful for patients treated with low-dose aspirin.
机译:低剂量阿司匹林广泛用于降低心脑血管血栓形成的风险,通常通过增加粘膜的通透性来诱发肠胃病。然而,尚未确定低剂量阿司匹林诱导的小肠损伤患者的治疗策略。我们评估了水ual水芹钠(一种胃保护剂,可抑制吲哚美辛诱导的大鼠小肠损伤)对健康成年男性志愿者低剂量阿司匹林引起的小肠粘膜损伤的预防作用。参与者被随机分配接受每日100?mg / kg的阿司匹林(对照组,n =?10)或每天服用100?mg / kg的阿司匹林加30?mg的例地碱钠(例地钠组,n =?10)。在开始给药两周后,通过胶囊内窥镜评估小肠粘膜损伤。在治疗前后进行粪便分析(隐血试验,免疫化学试验,转铁蛋白测定和钙卫蛋白测定)。依加仑钠显着抑制了胶囊内窥镜检查发现的小肠损伤的总数以及粪便潜血试验的阳性率。每天服用30 mg的牛磺酸钠对小剂量阿司匹林引起的小肠损伤具有预防作用。由于据报导酸抑制疗法会通过营养不良加重NSAIDs诱导的肠病,因此,例如乙草胺钠可能对低剂量阿司匹林治疗的患者有用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号